UK markets closed

Oramed Pharmaceuticals Inc. (ORMP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.1800-0.0600 (-2.68%)
At close: 04:00PM EDT
2.1800 0.00 (0.00%)
After hours: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/08/2021
31/08/2020
31/08/2019
Cash flows from operating activities
Net income
10,456
5,525
-36,561
-22,238
-11,511
-
Depreciation & amortisation
215
196
58
77
7
-
Stock-based compensation
5,333
4,212
11,509
2,695
465
-
Change in working capital
-2,506
-2,696
-943
-1,315
-3,158
-
Accounts payable
-2,788
-2,225
-376
2,060
-816
-
Other working capital
-6,279
-10,549
-28,414
-21,556
-12,522
-
Other non-cash items
-
1,472
22
1,040
38
-
Net cash provided by operating activities
-6,222
-10,295
-27,918
-21,181
-12,440
-
Cash flows from investing activities
Investments in property, plant and equipment
-57
-254
-496
-375
-82
-
Purchases of investments
-175,919
-190,919
-154,405
-53,822
-39,382
-
Sales/maturities of investments
146,139
118,135
185,086
30,434
44,091
-
Other investing activities
-
-
2
-1
-1
-3
Net cash used for investing activities
-29,837
-73,038
30,211
-23,764
4,626
-
Cash flows from financing activities
Debt repayment
-69,000
-50,000
0
-
-
-
Common stock issued
-2
2,428
11,500
79,983
23,773
-
Other financing activities
-
-
-783
1,500
-
-
Net cash used provided by (used for) financing activities
30,548
51,978
10,779
102,892
23,786
-
Net change in cash
-5,528
-31,409
13,008
57,949
15,967
-
Cash at beginning of period
24,104
40,464
27,456
19,296
3,329
-
Cash at end of period
18,593
9,055
40,464
77,245
19,296
-
Free cash flow
Operating cash flow
-6,222
-10,295
-27,918
-21,181
-12,440
-
Capital expenditure
-57
-254
-496
-375
-82
-
Free cash flow
-6,279
-10,549
-28,414
-21,556
-12,522
-